Vir Biotechnology, Inc.
VIR
$5.09
-$0.325-6.01%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -577.65M | -521.96M | -533.34M | -483.04M | -539.44M |
| Total Depreciation and Amortization | 12.91M | 14.56M | 16.15M | 17.84M | 18.33M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 125.46M | 145.06M | 150.30M | 161.15M | 156.18M |
| Change in Net Operating Assets | 24.20M | -84.01M | -99.75M | -146.94M | -397.46M |
| Cash from Operations | -415.08M | -446.35M | -466.64M | -450.99M | -762.39M |
| Capital Expenditure | -7.06M | -7.30M | -6.43M | -7.79M | -16.58M |
| Sale of Property, Plant, and Equipment | 3.12M | 3.37M | 917.00K | 912.00K | 533.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 601.70M | 503.30M | 259.33M | 83.14M | 111.02M |
| Cash from Investing | 597.77M | 499.37M | 253.82M | 76.26M | 94.97M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 69.00K | 0.00 | 22.00K | -4.00K | -3.00K |
| Issuance of Common Stock | 4.93M | 4.55M | 5.07M | 5.34M | 5.68M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -165.00K | -165.00K | -287.00K | -287.00K | -387.00K |
| Cash from Financing | 4.83M | 4.39M | 4.81M | 5.05M | 5.29M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 187.52M | 57.40M | -208.02M | -369.68M | -662.14M |